The DOI matches its Crossref record; 144 of the 145 references it cites were found in a registry or an index.
Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association
Open accessAbstract
Cardio-obstetrics has emerged as an important multidisciplinary field that requires a team approach to the management of cardiovascular disease during pregnancy. Cardiac conditions during pregnancy include hypertensive disorders, hypercholesterolemia, myocardial infarction, cardiomyopathies, arrhythmias, valvular disease, thromboembolic disease, aortic disease, and cerebrovascular diseases. Cardiovascular disease is the primary cause of pregnancy-related mortality in the United States. Advancing maternal age and preexisting comorbid conditions have contributed to the increased rates of maternal mortality. Preconception counseling by the multidisciplinary cardio-obstetrics team is essential for women with preexistent cardiac conditions or history of preeclampsia. Early involvement of the cardio-obstetrics team is critical to prevent maternal morbidity and mortality during the length of the pregnancy and 1 year postpartum. A general understanding of cardiovascular disease during pregnancy should be a core knowledge area for all cardiovascular and primary care clinicians. This scientific statement provides an overview of the diagnosis and management of cardiovascular disease during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Support from an interdisciplinary team that may include nutritionists, kinesiologists, pharmacists, and mental health specialists, in addition to obesity medicine specialists, can be particularly effective for facilitating lifestyle modification and weight loss.17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“More timely initiation of therapy is associated with improved cardiovascular clinical outcomes among individuals with hypertension, diabetes, and dyslipidemias.18,53”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, recent evidence suggests that counseling related to risk reduction for CKM syndrome in high-risk women should start in the prenatal period and continue until the completion of postpartum follow-up visits for the mother and baby.16–18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the lack of CVD event reduction, lifestyle modification with behavior change, healthy dietary modification, and physical activity, resulting in weight loss of 5% to 10%, causes improvements in CKM risk factors including remission of T2D,17,18 with the CKM benefits of lifestyle modification observed across a range of populations and geographic settings.19”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“dysregulation of these changes leading to excess insulin resistance, adipose deposition, hypercoagulability, cardiac remodeling, and decreased vascular resistance,12,18 may result in APOs.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adverse CKM risk factor levels (overweight/obesity, hypertension, hypertriglyceridemia, diabetes, CKD) during the prepregnancy period are associated with increased risk of APOs.18,29”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While waist-hip ratio provides improved characterization of metabolic and cardiovascular risk than waist circumference, challenges of complexity of measurement and lack of standardization make it less ideal for use in clinical settings.18,29–32”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Using both BMI and waist circumference provides complementary prognostic information regarding risk for future metabolic derangements, incident CVD, and mortality.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Regular assessments of lipids, glycemia, and kidney function (eg, eGFR) are recommended with increasing frequency for higher CKM stages, as the risk for progressive metabolic and kidney disease increases along the CKM spectrum.13,18–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Through these mechanisms, adverse SDOH lead to CKM risk factor development.16–20”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Modest weight loss of 5% to 10% among patients with overweight or obesity and diabetes is associated with improvement in glycemic measures, BP, HDL-C, and triglycerides, among others. This can result in risk reduction for incident CKM risk factors such as diabetes and hypertension.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Average excess weight loss is greater with RYGB (56%) than LSG (46%),2,18 with persistent differences at 10 years.4”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Bupropion/naltrexone, phentermine/topiramate, and orlistat have all shown efficacy in improving glycemia, and the latter 2, in reducing BP.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Clinical trials have indicated a lack of heterogeneity in the effects of each class of these cardioprotective glucose-lowering therapies between those who were and were not taking the other agent.17–19,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In patients with symptomatic PAD, semaglutide increases walking distance.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Treatment of obesity-related HFpEF with the GLP-1–based therapies semaglutide and tirzepatide achieves improvements in HF patient-reported health status and quality of life, functional capacity as measured by the 6-minute walk distance (6MWD), and freedom from worsening HF events, including HF hospitalizations.1,3,17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“One analysis was based on the results of the EMPEROR-PRESERVED trial, in which the effect of SLGT2i on cardiovascular mortality in HFpEF was not statistically significant (HR, 0.91; 95% CI, 0.76–1.09).”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Two high-quality simulation model–based cost-effectiveness analyses evaluated the economic value of adding SGLT2i therapy to prior GDMT in adults with symptomatic HFpEF, but neither study reported subgroup analyses by diabetes status.17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In a sensitivity analysis assuming a 9% cardiovascular mortality benefit, the ICER was $174 053 per QALY gained.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Prior studies performed using a US health care sector perspective and a lifetime analytic horizon noted that SGLT2i therapy was unlikely to be cost-effective for HFpEF, but that the incremental cost-effectiveness ratio was sensitive to the effect on mortality.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These analyses suggest that SGLT2i therapy is not cost-effective at current drug prices (incremental cost-effectiveness ratio ≥$120 000 per QALY gained), but these analyses pooled individuals with and without diabetes, and there may be additional cardiovascular and kidney benefits in individuals with diabetes.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Fibrosis stage best predicts adverse outcomes in MASLD.1,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“a lower eGFR, higher UACR, and higher CKD stages are associated with VTE development and worse outcomes.16–20”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Women planning pregnancy with diabetes are at greater risk of experiencing APOs compared to women without diabetes or those who develop GDM.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“An effective response to obesity pharmacotherapy has historically been described as at least 5% of body weight loss after 3 months of treatment.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“MBS, which induces body weight loss of >20%, also improves OSA, and is associated with reductions in CV and renal events, and in cardiovascular and all-cause mortality among people with OSA.3,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C.-T., Fesmire, F. M., Franklin, B. A., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,797
Erbel (2014) · doi:10.1093/eurheartj/ehu281 · Cited by 4,451
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,920
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,544
WRITING GROUP MEMBERS, Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d4739e · Cited by 2,346
Prognosis of Cerebral Vein and Dural Sinus Thrombosis
Ferro, J. M., Canhão, P., Stam, J., Bousser, M., & Barinagarrementería, F. (2004) · Stroke · doi:10.1161/01.str.0000117571.76197.26 · Cited by 2,309
Research works printed but not linked: 2
- Martin, JA, Hamilton, BE, Osterman, MJK, Driscoll, AK, Drake, P. Births: final data for 2017. Natl Vital Stat Rep. 2018;67:1–50.
- 10.1136/hrt.2006.095240 · DOI
Cited by
Sorted by citations
Items 201–300 of 474
Bond, R. M., Bello, N. A., Ansong, A. K., & Ferdinand, K. C. (2024) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2024.100445 · Cited by 4
Policy Change Needed to Improve Maternal Cardiovascular Health
Churchwell, K., Lloyd‐Jones, D. M., Harris, S. R., & Mehta, L. S. (2021) · Circulation · doi:10.1161/circulationaha.121.058054 · Cited by 4
Self-citationCardio-Obstetrics: Past, Present and Future
Grewal, J., Windram, J. D., & Silversides, C. K. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.09.010 · Cited by 4
Severe Maternal Cardiovascular Morbidity
Briller, J. E. (2022) · JACC Advances · doi:10.1016/j.jacadv.2022.100124 · Cited by 4
Yurista, S. R., Wadhera, P., Eder, R. A., Elkayam, U., & Siddiqi, O. K. (2024) · JACC Advances · doi:10.1016/j.jacadv.2023.100799 · Cited by 4
Dziewior, J., Carr, L. J., Pierce, G. L., Story, W. T., Gibbs, B. B., & Whitaker, K. M. (2024) · JMIR Formative Research · doi:10.2196/65611 · Cited by 3
Hypertensive disorders of pregnancy: A narrative review
Beaulac, A., Cumyn, A., Côté, A., & Caron, N. (2025) · Canadian Journal of General Internal Medicine · doi:10.3138/cjgim.2024.0032 · Cited by 3
Cardiovascular Disease in Pregnancy: When Two Hearts Beat as One
Tognola, C., Brucato, F., Maloberti, A., Varrenti, M., Preda, A., Mazzone, P., Giannattasio, C., & Guarracini, F. (2025) · Diagnostics · doi:10.3390/diagnostics15222921 · Cited by 3
Partani, E., Shi, C., Stram, D. A., Palakodeti, S., McDonald, M., Triplett, C., Ting, J. G., Stephenson, M. L., Joshi, N., & Pursnani, S. K. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.01.003 · Cited by 3
Cancer in Pregnancy: Therapeutic Decisions at the Intersection of Two Lives
Braga, A. R. F., Rezende-Filho, J., Magalhães, M., Sun, S. Y., de Melo, A. C., Callado, G. Y., Negraes, F. D. C., Fajardo, M. V. M., Fialho, S. C. A. V., Júnior, E. A., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16071070 · Cited by 3
Khan, S. S., Grobman, W. A., Perak, A. M., Angell, S. Y., Brubaker, L. T., Cameron, N. A., Ferranti, S., Khoudary, S. R. E., Ferranti, E. P., Hameed, A. B., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001483 · Cited by 3
Sasagasako, N., Kakigano, A., Kamiya, C., Tsuji, A., Sawada, A., & Yoshimatsu, J. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14961 · Cited by 3
Incidence and outcomes of acute high-risk chest pain diseases during pregnancy and puerperium
Wu, S., Xu, X., He, Q., Qin, Y., Wang, R., Chen, J., Chen, C., Wu, C., & Liu, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.968964 · Cited by 3
New Hypertension After Pregnancy in Patients With Heart Disease
Siu, S. C., Lee, D. S., Fang, J., Austin, P. C., & Silversides, C. K. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029260 · Cited by 3
Velásquez-Penagos, J. A., Muñoz-Ortiz, E., Toro-Lugo, C., Henao-Parra, D. A., Correa-Vásquez, M., Gándara, J. A., Zapata-Montoya, A. M., Holguín-Gonzalez, E., Giraldo-Ardila, N., Milena-Campo, S., et al. (2023) · Archivos de cardiología de México · doi:10.24875/acm.22000057 · Cited by 3
Verma, M., Kumar, A., Nanda, S., Chauhan, M. B., Dahiya, P., & Singhal, S. R. (2023) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v14i8.54698 · Cited by 3
Petersen, J. W., Abusnina, W. A., Beesabathina, S., Desu, S. S., Walters, R. W., & Alla, V. M. (2024) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-024-01950-0 · Cited by 3
Peripartum extracorporeal life support
Naoum, E., & Ortoleva, J. P. (2024) · BJA Education · doi:10.1016/j.bjae.2024.05.003 · Cited by 3
Pregnancy-Related Heart Disease in the Emergency Department
Hodgson, N. R., Lindor, R. A., Monas, J., Heller, K., Kishi, P., Thomas, A., Petrie, C., Querin, L. B., Urumov, A., & Majdalany, D. S. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15040148 · Cited by 3
Das, B. B., Aggarwal, V., & Deshpande, S. R. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i6.106295 · Cited by 5
Redefining care: The four pillars of women’s cardiovascular programs
Bond, R. M. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.08.003 · Cited by 3
Pregnancy following personalised aortic root support in Marfan syndrome
Coroyannakis, C., Tome, M., Watt‐Coote, I., & Cauldwell, M. (2022) · Obstetric Medicine · doi:10.1177/1753495x221078447 · Cited by 3
Development of delivery plans for pregnant women with complex heart disease
Canobbio, M. M., & Afshar, Y. (2022) · International Journal of Cardiology Congenital Heart Disease · doi:10.1016/j.ijcchd.2022.100375 · Cited by 3
Role of MicroRNAs in Cardiac Disease with Stroke in Pregnancy
Salma, U., Alshaikh, A. B. A., Alanazi, M. F., Alomair, B. M., Alruwaili, M., & AlRuwaili, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5260085 · Cited by 3
Ferraro, B. F., Shah, K., Krinock, M., Modi, V. A., Pandya, M., Thyagaturu, H. S., & Cutitta, C. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101425 · Cited by 3
Intrapartum trends of NT-proBNP and hs-cTnT in patients with severe features of preeclampsia
Fixler, J. S., Byrne, J. J., McIntire, D. D., Nelson, D. B., & Cunningham, F. G. (2023) · Pregnancy Hypertension · doi:10.1016/j.preghy.2023.11.006 · Cited by 3
Dyslipidemia in Pregnancy: How to Deal
Satpathy, H. K., Mohapatra, N., Das, B., Sethi, S. P., & Kumar, B. M. (2025) · Indian Journal of Cardiovascular Disease in Women · doi:10.25259/ijcdw_61_2025 · Cited by 3
Тhе features of a personalized approach to the treatment of cardiovascular diseases during pregnancy
Konkov, D. G., Булавенко, О. В., Adamchuk, N. V., & Kosianenko, S. М. (2021) · Reports of Vinnytsia National Medical University · doi:10.31393/reports-vnmedical-2021-25(3)-27 · Cited by 3
Carland, C., Panelli, D. M., Leonard, S. A., Bryant, E., Sherwin, E. B., Lee, C. J., Levin, E. G., Jimenez, S., Tremmel, J. A., Tsai, S. A., et al. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00978-z · Cited by 3
Anesthetic management of patients with peripartum cardiomyopathy
Eerdekens, G.-J., Devroe, S., Budts, W., & Rex, S. (2023) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001244 · Cited by 3
Hypertension in Women and Pregnancy
SHAH, A. A., Kapcin, K., Deicke, M., Pappan, N., Holden, K., Routray, S. K., Schmetzer, A., DUMONT, T. L., Nashar, K., Bajwa, O. A., et al. (2023) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000480 · Cited by 3
The Role of Biomarkers and Imaging to Predict Preeclampsia and Subsequent Cardiovascular Dysfunction
Woldu, B., Shah, L. M., Shaddeau, A., Goerlich, E., Zakaria, S., Hays, A. G., Vaught, A. “. J., Creanga, A. A., Blumenthal, R. S., & Sharma, G. V. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00913-6 · Cited by 3
Self-citationBridging the Gap in Maternal Cardiovascular Risk
Scott, N. S., Sarma, A. A., & Choi, E. (2023) · JACC Advances · doi:10.1016/j.jacadv.2022.100177 · Cited by 3
Management of arrhythmias during pregnancy
Albertini, L., & SPEARS, D. A. (2023) · Heart Rhythm O2 · doi:10.1016/j.hroo.2023.09.004 · Cited by 3
Meng, M., Hussey, H., & Arendt, K. W. (2026) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2026.104913 · Cited by 3
Reach and effectiveness of a non-university cardio-obstetrics program
Saxena, R., Benson, G. A., Sidebottom, A. C., Okeson, B. K., Hayes, J., Shaw, K. E., Baechler, C. J., & Wagner, W. (2024) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2024.2367090 · Cited by 2
Peripartum cardiomyopathy: a clinical review
Farroni, E., Taggiasco, A., & Santulli, G. (2025) · Vessel Plus · doi:10.20517/2574-1209.2025.15 · Cited by 2
Dong, Z., Luo, L., Zhuang, X., Fu, L., Yi, S., Wang, K., Jiang, Y., Yang, X., & Hei, F. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1637826 · Cited by 2
Advances in Diagnosis and Treatment of Acute and Chronic Heart Failure: A Comprehensive Review
Kenyon, C. R., Wyk, L. V., Flom, A. P., Ibrahim, R., Pham, H. N., Lakhdar, S., Iftikhar, M., & Abdelnabi, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020618 · Cited by 4
Cardiovascular-Related Maternal Mortality
Levine, L. D., Klammer, C., & Lewey, J. (2026) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000006297 · Cited by 3
Cardiometabolic Health in Pregnancy
Harrington, C. M., Sarma, A., Jowell, A. R., Passarelli, J., Powe, C. E., Bello, N. A., Lewey, J., Davis, M. B., Dastmalchi, L. N., Sharma, G. V., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102804 · Cited by 2
Self-citationThompson, A., Fleischmann, K. E., Smilowitz, N. R., Fuentes, L. D. L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001472 · Cited by 2
Khan, S. S., Grobman, W. A., Angell, S. Y., Brubaker, L. T., Cameron, N. A., Ferranti, S., Khoudary, S. R. E., Ferranti, E. P., Hameed, A. B., Johnson, H. M., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001482 · Cited by 2
Feldman, D. I., Wu, K. C., Hays, A. G., Marvel, F. A., Martin, S. S., Blumenthal, R. S., & Sharma, G. V. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100181 · Cited by 2
Self-citationNg, K. S., Li, K. F. C., Tan, C. K., & Ong, P. J. L. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2204157 · Cited by 2
Wild, R. A., Edwards, R. K., Zhao, D.-X., Hansen, K. R., Kim, A. S., & Wrenn, D. S. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01197-w · Cited by 2
Surgical emergencies in the pregnant patient
Sonderman, K. A., Golden, A. C., Vora, P. M., Naoum, E. E., Kyaw, C. A., Saclarides, C., Afrasiabi, M. R., Yee, S., Wu, C. M., Anderson, G. A., et al. (2023) · Current Problems in Surgery · doi:10.1016/j.cpsurg.2023.101304 · Cited by 2
Care for the Obstetric Patient with Complex Cardiac Disease
Vinsard, P. A., Arendt, K. W., & Sharpe, E. E. (2023) · Advances in Anesthesia · doi:10.1016/j.aan.2023.05.004 · Cited by 2
Ferranti, E. P., Martyn-Nemeth, P. A., Walter, K., Hayman, L. L., Langdon, K. D., Villavaso, C. D., VanBrocklin, L., & Bryant, E. (2023) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000001020 · Cited by 2
Al-Allak, H. M. A., & Al-Aboodi, A. H. N. (2023) · Cureus · doi:10.7759/cureus.46342 · Cited by 2
Myocardial Infarction in Pregnancy: What Should We Do?
Laksono, S., & Wening, T. L. (2024) · South East European Journal of Cardiology · doi:10.3889/seejca.2024.6067 · Cited by 2
Changes in rate-pressure product associated with pregnancy
Schenone, C. V., Cain, M. A., Schenone, A. L., Smith, T., Tsalatsanis, A., Louis, J. M., & Crousillat, D. R. (2024) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2024.101338 · Cited by 2
Cardiovascular complications during pregnancy: Advancing cardio-obstetrics
Sebastian, S. A., Sethi, Y., Mathews, A. M., Santhosh, T., Co, E. L., Padda, I., & Johal, G. (2024) · Disease-a-Month · doi:10.1016/j.disamonth.2024.101780 · Cited by 2
Percutaneous Coronary Intervention in Pregnancy: A Contemporary Review
Bolaji, O. A., Bahar, Y., Bahar, Y., Adabale, O. K., Anuforo, A. C., Echari, B., Bob‐Manuel, T., Nebuwa, C. N., & Alraies, M. C. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000945 · Cited by 2
Transcatheter Structural Heart Interventions in Women
Chung, J., Yang, K. L., Nozadze, N., Kukarni, A., Ashwath, M. L., Bui, Q., Co‐Vu, J., Jone, P., Lyubarova, R., & Andrade-Bucknor, S. N. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02254-3 · Cited by 2
Numasawa, Y., Yokokura, S., Maeda, T., Daigo, K., Sakata, S., Hashimoto, R., Taruoka, A., Sato, K., Haginiwa, S., Kojima, H., et al. (2020) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2020.09.009 · Cited by 2
Electrocardiographic Changes in Pregnant Women with COVID-19
Yousefzadeh, M., Asgarian, A., Ahangari, R., Vahedian, M., & Mirzaie, M. (2022) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_9_22 · Cited by 2
Peripartum Spontaneous Coronary Artery Dissection
Yao, H., Ekou, A. K., N’Djessan, J. J., Soya, E., Kyandabike, R. K., Vy, L., Ehouman, E., Sepih, E., Adoubi, A. K., & N’Guetta, R. (2023) · JACC Case Reports · doi:10.1016/j.jaccas.2023.102099 · Cited by 2
Mortalité maternelle par pathologies cardiovasculaires en France 2016–2018
Bruyère, M., Morau, E., & Verspyck, É. (2024) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2024.02.012 · Cited by 2
Cruz, M. A. B., & Ma. Concepcion L. Cruz, M. (2024) · Acta Medica Philippina · doi:10.47895/amp.v58i9.8746 · Cited by 2
Cardio-Obstetrics Practice in Latin America
Herrera, C. J., Mateo, J., Goldberg, R., Romero, L. M., Henriquez, P. M., Cruz, L., Pimentel, C., Lorenzatti, A. J., Higa, C. C., Saldarriaga, C., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101295 · Cited by 2
Maternal cardiovascular research and education should be prioritized in the United States
Collins, H. E. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00751.2024 · Cited by 2
Hypertension in the Pregnant Teenager
Hunley, T. E., & Jones, D. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-06231-5_28 · Cited by 3
Considerations for specific cardiomyopathies during pregnancy
Abrams, M., Magun, E., & DeFilippis, E. M. (2023) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001033 · Cited by 2
The Role of Nurses in Fetal Cardiology Programs
Butler, M., & McArthur, E. C. (2023) · MCN The American Journal of Maternal/Child Nursing · doi:10.1097/nmc.0000000000000910 · Cited by 2
The development of adult congenital heart disease care in the United States
Daniels, C. J. (2023) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2023.101400 · Cited by 2
Management of the Pregnant Woman with Congenital Heart Disease
Park, A., Barbera, K., Rose, C. H., Steury, R., Downing, T. E., Ito, S., & John, A. S. (2023) · Springer eBooks · doi:10.1007/978-3-030-42937-9_98-1 · Cited by 2
Management of Friedreich Ataxia–Associated Cardiomyopathy in Pregnancy: A Review of the Literature
Peterson, A. N., Hickerson, L. C., Pschirrer, E. R., Friend, L. B., & Taub, C. C. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.10.019 · Cited by 2
Dios, J. Á. T., & Benítez, S. P. (2021) · Revista Española de Anestesiología y Reanimación (English Edition) · doi:10.1016/j.redare.2020.09.008 · Cited by 2
Is Cardiac Surgery Safe During Pregnancy?
Jahangiri, M., & Thilaganathan, B. (2024) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2024.08.011 · Cited by 2
Cifuentes, J. M., & Fardelmann, K. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-62756-9_6 · Cited by 2
Zaleski, K. L., Blazey, M. H., Carabuena, J. M., Economy, K. E., Valente, A. M., & Nasr, V. G. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2022.09.001 · Cited by 1
Self-citationSurgical treatment of pulmonary embolism in a 25-week pregnant woman
Lazoryshynets, V. V., CHERNUKHA, L., Сіромаха, С. О., Rusnak, A. O., KHREBTIY, Y., SKUPII, O., & SERGIICHUK, O. L. (2022) · Acta Phlebologica · doi:10.23736/s1593-232x.22.00535-5 · Cited by 1
Hart, W. M., Cobb, B., Quist‐Nelson, J., & Tully, K. P. (2024) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2024.101336 · Cited by 1
Narvaez-Guerra, O. D., Sorour, N., Aurigemma, G. P., Parker, M. W., Kanter, D. J., & Kovell, L. C. (2024) · CASE · doi:10.1016/j.case.2023.12.013 · Cited by 1
Șulea, C. M., Kiss, A. B., Ágg, B., Benke, K., Bartha, E., Szilveszter, B., Stengl, R., Csonka, M., Szabolcs, Z., & Pólos, M. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03357-2 · Cited by 1
Fok, C. L., Sulley, S., Aroche, A., McDaniel, D., & Frazier, D. (2025) · Discover Public Health · doi:10.1186/s12982-025-00634-2 · Cited by 1
Wilkie, G., Semenov, E., Leung, K., Nelson, B. B., Scott, N. S., & Harrington, C. M. (2025) · Obstetric Medicine · doi:10.1177/1753495x251347767 · Cited by 1
Evaluating Knowledge Gaps in Cardio-Obstetrics
Houri, O., & Pravda, N. S. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.102040 · Cited by 1
Enrollment of all-female and lactating or pregnant female participants in cardiovascular trials
Pine, P. L. S., Rivera, F. B., Magalong, J. V., Bantayan, N. R. B., Tesoro, N. A., Tsai, C.-M., & Gulati, M. (2025) · npj Cardiovascular Health · doi:10.1038/s44325-025-00084-4 · Cited by 1
Maternal and neonatal outcomes in Marfan syndrome: a nationwide registry
Chang, F., Chen, C.-Y., Hsieh, M., Lin, C., Cheng, Y.-T., Wu, V. C., Yeh, C., Chu, P., Chou, A.-H., & Chen, S. (2025) · Heart · doi:10.1136/heartjnl-2025-326111 · Cited by 1
Acute Myocardial Infarction in Pregnancy: A Multidisciplinary Approach
Ghafoor, H., Haider, F., Zeba, A., Kumar, N., Huda, A. U., Naz, A., Padmalayam, P., Ashraf, K., Ahmed, O., Karunakaran, E., et al. (2026) · Cureus · doi:10.7759/cureus.102240 · Cited by 1
Das, B. B., Kwan, M., & Upadhyay, S. (2026) · Journal of Cardiac Failure - Intersections · doi:10.1016/j.yjcafi.2026.01.010 · Cited by 1
Valvular Heart Disease During Pregnancy: Outcomes from a Large Integrated Healthcare System
Palakodeti, S., Triplett, C., Stram, D. A., Stephenson, M. L., & Pursnani, S. K. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.03.011 · Cited by 1
Maternal age and pregnancy-related cardiovascular complications
Kamel, H., Riley, L. E., Son, M., Karas, M. G., Roman, M. J., Sancho, M. T. D., Fink, M. E., Liberman, A. L., & Navi, B. B. (2026) · Nature Communications · doi:10.1038/s41467-026-72580-9 · Cited by 1
Acute coronary syndromes across the lifespan of women
Donisan, T., Hagan, G., Tweet, M. S., Bell, M. R., & Hayes, S. N. (2026) · npj Cardiovascular Health · doi:10.1038/s44325-026-00126-5 · Cited by 1
Vanharen, Y., Stocker, L. J., MacKillop, L., Berendoncks, A. V., Mannaerts, D., Goossens, E., Mulders, A., Kauling, R. M., & Schoenaker, D. A. J. M. (2026) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2026.115213 · Cited by 1
Clinical Considerations in Management of Hypertrophic Cardiomyopathy in Pregnancy
Abdelfattah, O., Abdeldayem, J., Hassan, A. A., Gulati, M., Phillips, S., Ownes, A. T., Sharma, G. V., Wood, M. J., Pirwitz, M. J., Shepherd, M. C., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.06.004 · Cited by 1
Self-citationBrazile, T. L., Conrad, N., Bergman, L., Paul, G. J., Mehta, L. S., Silversides, C. K., Sliwa, K. S., Sharma, G. V., Sharma, G. V., Brazile, T. L., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(26)01234-1 · Cited by 1
Self-citationA Case Series of Parturients With Mechanical Mitral Valves
Nicholas, A. K., Countouris, M. E., Jeyabalan, A., & Lim, G. (2023) · JACC Case Reports · doi:10.1016/j.jaccas.2023.101741 · Cited by 1
O manejo cardiovascular durante a gestação
do Nascimento, A. C. M., Anna Clara Melo do Nascimento, de Vasconcelos, A. V., Anna Victoria de Vasconcelos, Filho, C. A. A. D., Dias, C. B. L. M., Carlos Benjamim Lino Moraes Dias, Carlos Daniel Lobato da Costa, Lima, E. R. L., Eduardo Rennan Lopes Lima, et al. (2023) · doi:10.22533/at.ed.511232209 · Cited by 1
Naz, S., Rehman, S., Hussain, W., Hakeem, A., & Bhatti, S. (2024) · JACC Case Reports · doi:10.1016/j.jaccas.2024.102622 · Cited by 1
Cardiac Rehabilitation for Women with Heart Disease
Whiteson, J. H., Prilik, S., & Glenn, M. C. (2025) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2024.11.005 · Cited by 1
Tomlinson, M. W., D'Mello, R. J., Tam, L. M., & Gonik, B. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009643115 · Cited by 1
Watkins, J. M., Goss, J. M., Mehls, K. D., Dlugonski, D., & Downs, D. S. (2025) · Healthcare · doi:10.3390/healthcare13233127 · Cited by 1
From menarche to menopause: estrogenic influences on stroke-related depression in women
Tierney, L. K., Diaz, I. C., Patel, S. H., & Raval, A. P. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101232 · Cited by 1
The Effect of Mindfulness-Based Counseling Program on Academic Stress among College Students
Shinta, D., Khan, R., & Amin, R. (2025) · Research Psychologie Orientation et Conseil · doi:10.70177/rpoc.v2i1.1855 · Cited by 1
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., Fuentes, L. D. L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.06.017 · Cited by 1
Electrocardiogramas durante el tercer trimestre de embarazo: descripción de sus características
Battioni, L., Eídelman, G., Enriquez, B., Herscovich, N., Arismendi, L., & Deviggiano, A. (2021) · Revista Argentina de Cardiología · doi:10.7775/rac.es.v89.i2.20011 · Cited by 1
Pitfield, S., Bedard, A., Bashir, J. G., Bruce, S., Augoustides, J. G., Cormican, D. S., Marchant, B. E., & Fernando, R. J. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2022.09.098 · Cited by 1
Metadata
- Authors
- Mehta, L. S., Warnes, C. A., Bradley, E., Burton, T., Economy, K., Mehran, R., Safdar, B., Sharma, G., Wood, M., Valente, A. M., Volgman, A. S., & On behalf of the American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. A. S. C.
- ORCID
- Venue
- Circulation
- Published
- 2020-06-09
- Volume
- 141
- Issue
- 23
- Pages
- e884-e903
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3022591273
- Semantic Scholar
- a4f99c537a938a755723900351845a99644d8796
- Cited by
- 464
- References
- 145
- Citations by year
- 2026: 96 · 2025: 69 · 2024: 70 · 2023: 81 · 2022: 75 · 2021: 56 · 2020: 17
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Issues in Pregnancy
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
- Keywords
- cardiovascular disease in pregnancy, cardio-obstetrics, maternal mortality, hypertensive disorders of pregnancy, preeclampsia, hypercholesterolemia, myocardial infarction, cardiomyopathy, cardiac arrhythmias, valvular heart disease, thromboembolism, aortic disease, cerebrovascular disease, preconception counseling, maternal morbidity, postpartum care
- MeSH terms
- American Heart Association, Female, Humans, Postnatal Care, Pregnancy, Pregnancy Complications, Cardiovascular, United States, Delivery, Obstetric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
